{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:01:10Z","timestamp":1773154870239,"version":"3.50.1"},"reference-count":73,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2014.00023","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T09:03:42Z","timestamp":1409216622000},"source":"Crossref","is-referenced-by-count":23,"title":["Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?"],"prefix":"10.3389","volume":"1","author":[{"given":"Stefano","family":"Guandalini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"B1","first-page":"739","article-title":"Childhood functional gastrointestinal disorders: child\/adolescent","volume-title":"Rome III: The Functional Gastrointestinal Disorders","author":"Di Lorenz","year":"2006","edition":"3rd ed"},{"issue":"2","key":"B2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0022-3476(96)70246-9","article-title":"Abdominal pain and irritable bowel syndrome in adolescents: a community-based study","volume":"129","author":"Hyams","year":"1996","journal-title":"J Pediatr"},{"issue":"9","key":"B3","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1111\/j.1572-0241.2002.05783.x","article-title":"Epidemiology and health care seeking in the functional GI disorders: a population-based study","volume":"97","author":"Koloski","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"B4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/j.gastro.2005.11.057","article-title":"Psychosocial aspects of the functional gastrointestinal disorders","volume":"130","author":"Levy","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"B5","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.05.006","article-title":"Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature","author":"Duricova","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"6","key":"B7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MCG.0b013e3182549092","article-title":"World gastroenterology organisation global guidelines: probiotics and prebiotics October 2011","volume":"46","author":"Guarner","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"B8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/10408399309527616","article-title":"Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects","volume":"33","author":"Roberfroid","year":"1993","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/15476910802019045","article-title":"Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action","volume":"5","author":"Novak","year":"2008","journal-title":"J Immunotoxicol"},{"issue":"8","key":"B10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"B11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","article-title":"Intestinal microbiota in functional bowel disorders: a Rome foundation report","volume":"62","author":"Simr\u00c3\u00a9n","year":"2013","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/gmic.29417","article-title":"The microbiota-gut-brain axis in functional gastrointestinal disorders","volume":"5","author":"De Palma","year":"2014","journal-title":"Gut Microbes"},{"issue":"5","key":"B13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1053\/j.gastro.2005.08.063","article-title":"Childhood functional gastrointestinal disorders: child\/adolescent","volume":"130","author":"Rasquin","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"B14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0016-5085(91)90275-P","article-title":"Irritable bowel syndrome in office-based practice in the United States","volume":"100","author":"Everhart","year":"1991","journal-title":"Gastroenterology"},{"issue":"2","key":"B15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jpeds.2005.05.015","article-title":"The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial","volume":"147","author":"Bausserman","year":"2005","journal-title":"J Pediatr"},{"issue":"12","key":"B16","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1136\/gut.2007.119446","article-title":"Guidelines on the irritable bowel syndrome: mechanisms and practical management","volume":"56","author":"Spiller","year":"2007","journal-title":"Gut"},{"issue":"4","key":"B17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00384-011-1363-9","article-title":"A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome","volume":"27","author":"Kruis","year":"2012","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"B18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2982.2006.00879.x","article-title":"Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date","volume":"19","author":"Quigley","year":"2007","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"B19","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"B20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jpeds.2007.11.042","article-title":"Post-infectious functional gastrointestinal disorders in children","volume":"152","author":"Saps","year":"2008","journal-title":"J Pediatr"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","article-title":"The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects","volume":"133","author":"Kassinen","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"B22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2982.2012.01891.x","article-title":"Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome","volume":"24","author":"Carroll","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"B23","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1053\/j.gastro.2011.06.072","article-title":"Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome","volume":"141","author":"Saulnier","year":"2011","journal-title":"Gastroenterology"},{"issue":"11","key":"B24","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s10620-011-1730-y","article-title":"Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat","volume":"56","author":"Johnson","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"11","key":"B25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrmicro2876","article-title":"The interplay between the intestinal microbiota and the brain","volume":"10","author":"Collins","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"B26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/gast.2001.21908","article-title":"Management of the irritable bowel syndrome","volume":"120","author":"Camilleri","year":"2001","journal-title":"Gastroenterology"},{"issue":"17","key":"B27","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.3748\/wjg.14.2650","article-title":"Meta-analysis of probiotics for the treatment of irritable bowel syndrome","volume":"14","author":"McFarland","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"1","key":"B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MPG.0b013e3181ca4d95","article-title":"VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study","volume":"51","author":"Guandalini","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"B29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/apa.12513","article-title":"Probiotics for childhood functional gastrointestinal disorders: a systematic review and meta-analysis","volume":"103","author":"Korterink","year":"2014","journal-title":"Acta Paediatr"},{"issue":"2","key":"B30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2036.2006.03175.x","article-title":"A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children","volume":"25","author":"Gawronska","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2010.01797.x","article-title":"Lactobacillus reuteri in children with functional abdominal pain (FAP)","author":"Romano","year":"2010","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"B32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2036.2012.05180.x","article-title":"Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea \u00e2\u20ac\u201c a double-blind study","volume":"36","author":"Francavilla","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"B33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jpeds.2004.10.022","article-title":"Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial","volume":"146","author":"Banaszkiewicz","year":"2005","journal-title":"J Pediatr"},{"issue":"4","key":"B34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1442-200X.2007.02397.x","article-title":"Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation","volume":"49","author":"Bu","year":"2007","journal-title":"Pediatr Int"},{"issue":"34","key":"B35","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.3748\/wjg.v17.i34.3916","article-title":"Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial","volume":"17","author":"Guerra","year":"2011","journal-title":"World J Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2431-9-22","article-title":"Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571)","volume":"9","author":"Tabbers","year":"2009","journal-title":"BMC Pediatr"},{"issue":"4","key":"B37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MOG.0b013e328353e61e","article-title":"Inflammatory bowel disease pathogenesis: what is new?","volume":"28","author":"Scharl","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"B38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1586\/eci.09.70","article-title":"Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease","volume":"6","author":"Guandalini","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"B39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijmm.2009.08.005","article-title":"Mechanisms of probiotic actions \u00e2\u20ac\u201c a review","volume":"300","author":"Oelschlaeger","year":"2010","journal-title":"Int J Med Microbiol"},{"issue":"6","key":"B40","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2165\/11632710-000000000-00000","article-title":"Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients","volume":"72","author":"Jonkers","year":"2012","journal-title":"Drugs"},{"issue":"4","key":"B41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/00004836-199712000-00021","article-title":"Crohn\u00e2\u20ac\u2122s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn\u00e2\u20ac\u2122s disease?","volume":"25","author":"Malchow","year":"1997","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"B42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/gut.51.3.405","article-title":"Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn\u00e2\u20ac\u2122s disease: a randomised controlled trial with Lactobacillus GG","volume":"51","author":"Prantera","year":"2002","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-230X-4-5","article-title":"Lactobacillus GG in inducing and maintaining remission of Crohn\u00e2\u20ac\u2122s disease","volume":"4","author":"Schultz","year":"2004","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"B44","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/gut.2005.076604","article-title":"Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn\u00e2\u20ac\u2122s disease: a randomised, double blind, placebo controlled GETAID trial","volume":"55","author":"Marteau","year":"2006","journal-title":"Gut"},{"issue":"2","key":"B45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ibd.20063","article-title":"Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn\u00e2\u20ac\u2122s disease after lleo-caecal resection","volume":"13","author":"Van Gossum","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.MIB.0000437495.30052.be","article-title":"Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn\u00e2\u20ac\u2122s disease, and pouchitis: meta-analysis of randomized controlled trials","volume":"20","author":"Shen","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"B47","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1365-2036.2010.04417.x","article-title":"Clinical trial: the microbiological and immunological effects of synbiotic consumption \u00e2\u20ac\u201c a randomized double-blind placebo-controlled study in active Crohn\u00e2\u20ac\u2122s disease","volume":"32","author":"Steed","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"B48","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/01.MIB.0000175905.00212.2c","article-title":"A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn\u00e2\u20ac\u2122s disease","volume":"11","author":"Bousvaros","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"B49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ajg.2008.118","article-title":"Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis","volume":"104","author":"Miele","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"B50","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ibd.21222","article-title":"Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis","volume":"16","author":"Ng","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"B51","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cgh.2009.07.016","article-title":"The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis","volume":"7","author":"Sood","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"B52","first-page":"i126","article-title":"Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis","volume":"10","author":"Tursi","year":"2004","journal-title":"Med Sci Monit"},{"issue":"10","key":"B53","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/ajg.2010.218","article-title":"Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study","volume":"105","author":"Tursi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2014.07.442","article-title":"Complete genome sequence of the Gram-negative probiotic Escherichia coli strain Nissle 1917","author":"Reister","year":"2014","journal-title":"J Biotechnol"},{"issue":"9","key":"B55","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1055\/s-2008-1027463","article-title":"Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study","volume":"46","author":"Henker","year":"2008","journal-title":"Z Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.001","article-title":"Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial","author":"Petersen","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"3","key":"B57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2036.2011.04939.x","article-title":"Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis","volume":"35","author":"Oliva","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"7 Suppl","key":"B58","doi-asserted-by":"crossref","first-page":"1451S","DOI":"10.1093\/jn\/129.7.1451S","article-title":"Controlled trial of oligofructose in the management of irritable bowel syndrome","volume":"129","author":"Hunter","year":"1999","journal-title":"J Nutr"},{"issue":"6","key":"B59","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ajcn\/72.6.1570","article-title":"Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome","volume":"72","author":"Olesen","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"B60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1017\/S000711450779894X","article-title":"The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders","volume":"99","author":"Paineau","year":"2008","journal-title":"Br J Nutr"},{"issue":"5","key":"B61","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2036.2008.03911.x","article-title":"Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome","volume":"29","author":"Silk","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"B62","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/j.1440-1746.2010.06370.x","article-title":"Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome","volume":"25","author":"Ong","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"B63","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrgastro.2013.259","article-title":"Mechanisms and efficacy of dietary FODMAP restriction in IBS","volume":"11","author":"Staudacher","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"B64","doi-asserted-by":"publisher","first-page":"A35","DOI":"10.1136\/gutjnl-2014-307263.70","article-title":"OC-070 dietary supplementation with fodmaps increases fasting colonic volume and breath hydrogen in healthy volunteers: a mechanistic study using Mri","volume":"63","author":"Major","year":"2014","journal-title":"Gut"},{"issue":"2","key":"B65","first-page":"257","article-title":"Germinated barley foodstuff suppresses dextran sulfate experimental colitis in rats: the role of mast cells","volume":"19","author":"Araki","year":"2007","journal-title":"Int J Mol Med"},{"issue":"11","key":"B66","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1136\/gut.52.11.1572","article-title":"Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats","volume":"52","author":"Bovee-Oudenhoven","year":"2003","journal-title":"Gut"},{"issue":"1","key":"B67","first-page":"65","article-title":"Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment","volume":"9","author":"Fukuda","year":"2002","journal-title":"Int J Mol Med"},{"issue":"11","key":"B68","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.MIB.0000183421.02316.d5","article-title":"Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation","volume":"11","author":"Hoentjen","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"B69","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/gut.2005.074971","article-title":"Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn\u00e2\u20ac\u2122s disease","volume":"55","author":"Lindsay","year":"2006","journal-title":"Gut"},{"issue":"7","key":"B70","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn\u00e2\u20ac\u2122s disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"issue":"8","key":"B71","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1046\/j.1440-1746.2002.02709.x","article-title":"A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis","volume":"17","author":"Bamba","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 14","key":"B72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF03326417","article-title":"Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial","volume":"37","author":"Kanauchi","year":"2002","journal-title":"J Gastroenterol"},{"issue":"9","key":"B73","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1365-2036.2007.03288.x","article-title":"Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin","volume":"25","author":"Casellas","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Frontiers in Medicine"],"original-title":[],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T07:46:23Z","timestamp":1565768783000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2014.00023\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":73,"URL":"https:\/\/doi.org\/10.3389\/fmed.2014.00023","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}